Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The KRTAP13-3 gene affects wool fibre diameter variability in Chinese Tan sheep.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Managing multiple autoimmune diseases in one patient is very challenging.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

The p.P25L mutation in the KRT5 gene causes a rare skin condition that worsens over time and may lead to hair loss starting in young adulthood.

The ZIP13 variant is linked to abnormal hair quality.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

The document cannot be understood or processed.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Two patients with stubborn hair loss grew hair after PDRN injections.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Fzd2 is important for skin and hair development through various signaling ways.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

A specific gene mutation causes a rare hair loss condition in a Chinese patient.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Certain gene combinations improve cashmere quality and production in Liaoning goats.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Hair regrowth improved, but quality of life did not.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.